AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Impact BioMedical, Inc.
XASE · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG01JFZG023
3.60▼ 0.20 (-5.26%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
3.80
Day's Range
3.54 – 4.02
52-Week Range
0.37 – 7.11
Volume
11.7K
Avg Volume
43.5K
Share Statistics
Shares Outstanding
Employees
8
Exchange
XASE
Listed
2024-09-16
Share count as of August 4, 2026

Impact BioMedical, Inc. (IBO) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Impact BioMedical, Inc. (IBO)
What is Impact BioMedical, Inc.'s Market Cap?
Impact BioMedical, Inc.'s Market Cap is $388.2M, based on as-reported figures from SEC (XBRL) filings.
What is Impact BioMedical, Inc.'s Enterprise Value?
Impact BioMedical, Inc.'s Enterprise Value is $388.1M, based on as-reported figures from SEC (XBRL) filings.
What is Impact BioMedical, Inc.'s Trailing P/E?
Impact BioMedical, Inc.'s Trailing P/E is 490.7×, based on as-reported figures from SEC (XBRL) filings.
What is Impact BioMedical, Inc.'s Price / Sales?
Impact BioMedical, Inc.'s Price / Sales is 11090.2×, based on as-reported figures from SEC (XBRL) filings.
What is Impact BioMedical, Inc.'s EV / Revenue?
Impact BioMedical, Inc.'s EV / Revenue is 11089.9×, based on as-reported figures from SEC (XBRL) filings.
What is Impact BioMedical, Inc.'s EV / EBITDA?
Impact BioMedical, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Impact BioMedical, Inc.'s Revenue (TTM)?
Impact BioMedical, Inc.'s Revenue (TTM) is $35.0K, based on as-reported figures from SEC (XBRL) filings.
What is Impact BioMedical, Inc.'s Net Income (TTM)?
Impact BioMedical, Inc.'s Net Income (TTM) is $791.0K, based on as-reported figures from SEC (XBRL) filings.
What is Impact BioMedical, Inc.'s EBITDA?
Impact BioMedical, Inc.'s EBITDA is -$4.0M, based on as-reported figures from SEC (XBRL) filings.
What is Impact BioMedical, Inc.'s Diluted EPS (TTM)?
Impact BioMedical, Inc.'s Diluted EPS (TTM) is 0.01, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · IBOAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue:
Revenue
YoY growth-57.1%———
Costs and expenses:
Cost of Revenue—
Selling, General and Administrative Expense
Professional Fees
Research and Development Expense
Depreciation Expense
Rent and utilities
Other Expense
Total costs and expenses
Operating loss
% of revenue-23400.0%-32700.0%-16714.3%-5266.7%
Other income (expense):
Interest and Dividend Income (Non-Bank)——
Change in fair value of note payable, related party——
Interest expense——
Loss from operations before income taxes
Income tax benefit————
Net loss
% of revenue-23333.3%-32628.6%74785.7%-8194.4%
Loss (income) from operations attributed to noncontrolling interest
Net loss attributable to common stockholders
% of revenue-23300.0%-32671.4%74928.6%-8166.7%
Earnings Per Share (Basic)—
Earnings Per Share (Diluted)—